This report analyzes the US and the European markets for Cosmetic Procedures and Products in US$ Million. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The US market in the report is analyzed in terms of both Cosmetic Surgery Products and Cosmetic Procedures. The major product segments analyzed under the Cosmetic Surgery Products Category include - Equipment (Lasers, Microdermabrators, and Other Equipment), Injectables (Botulinum Toxin Type A, Dermal Fillers, and Other Injectables), Implants (Breast Implants, and Other Implants), and others. Major segments covered under the Cosmetic Surgery Procedures Category include - Surgical Procedures (Breast Augmentation, Abdominoplasty, Blenpharoplasty, Facelift, Liposuction, Rhinoplasty, and Others) and Non-Surgical Procedures (Botox, Dermal Fillers, Laser Hair Removal, Laser Skin Resurfacing, Chemical Peel, Microdermabrasion, and Others). The European market is analyzed for only Cosmetic Procedures by the following product segments - Surgical Procedures (Breast Augmentation, Liposuction, Blepharoplasty, Rhinoplasty) and Non-Surgical Procedures. The report profiles 76 companies including many key and niche players such as Allergan, Inc., Anika Therapeutics, Merz Aesthetics, Candela Corporation, Cutera Inc., Cynosure, Inc., DermaMed Solutions, Dermik Laboratories, Valeant Pharmaceuticals International, Inc., ExcellaDerm Corporation, Genesis Biosystems Inc., Johnson & Johnson, Mentor Corp., Lumenis Ltd., Medicis Pharmaceutical Corporation, Palomar Medical Technologies, Inc., Q-Med AB, Solta Medical, Inc., and Suneva Medical, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based upon search engine sources in the public domain.